G protein modulation by estrogens

https://doi.org/10.1016/0303-7207(91)90096-BGet rights and content

Abstract

Levels of various G protein subunits were assayed by immunoblot and densitometry, using specific antibodies, in anterior pituitaries and striata of female rats exposed to physiological or pharmacological modifications of ovarian hormone levels and, for comparison, in the same tissues of coeval male rats. Treatment of ovariectomized rats with 17β-estradiol 10 μg/rat/day for 5, 10 or 20 days induced a time-dependent rise in plasma prolactin (PRL) levels. While no change in G protein levels was observed in the striatum, estrogen treatment induced a significant reduction of all pituitary G protein levels except those of αil, which remained unchanged, and of αs42, which increased in a time-dependent manner. A highly significant correlation was observed between pituitary αs42 values and plasma PRL levels. During the estrous cycle, pituitary values of αo, αi3 and αs47 were generally lower than those of ovariectomized rats, suggesting the existence of tonic inhibitory influence of circulating ovarian hormones. Pituitary levels of αo, αil and αs42 also showed a significant modulation during the various phases of the estrous cycle, and those of αo, αi3, αs47 and β were significantly lower in female than in male rats. No significant effects of estrous cycle hormone variations or sex differences were observed in the values of striatum G proteins.

In conclusion, these data clearly indicate that ovarian hormones, and particularly estrogens, have a significant and specific effect on pituitary G protein levels which may modulate the secretion of pituitary hormones such as PRL.

References (51)

  • G.M. Bokoch et al.

    J. Biol. Chem.

    (1983)
  • B. Borgundvaag et al.

    Mol. Cell. Endocrinol.

    (1988)
  • C. Bouvier et al.

    Mol. Cell. Endocrinol.

    (1991)
  • M.L. Caron et al.

    J. Biol. Chem.

    (1978)
  • J.J. Fernandez-Ruiz et al.

    Brain Res.

    (1989)
  • P. Goldsmith et al.

    J. Biol. Chem.

    (1987)
  • R.M. Harris-Warrick et al.

    Neuron

    (1988)
  • D. Lévesque et al.

    Neurosci. Lett.

    (1988)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • R. Mattera et al.

    J. Biol. Chem.

    (1989)
  • T. Nakamura et al.

    J. Biol. Chem.

    (1985)
  • H. Ohta et al.

    J. Biol. Chem.

    (1985)
  • M. Pizzi et al.

    Brain Res.

    (1988)
  • S.E. Senogles et al.

    J. Biol. Chem.

    (1987)
  • A.M. Spiegel

    Mol. Cell. Pharmacol.

    (1987)
  • L. Vallar et al.

    Trends Pharmacol. Sci.

    (1989)
  • C. Van Dop et al.

    J. Biol. Chem.

    (1984)
  • A. Yatani et al.

    J. Biol. Chem.

    (1988)
  • B. Attali et al.

    J. Neurochem.

    (1989)
  • L. Birnbaumer et al.
  • A.M. Brandi et al.

    Neuroendocrinology

    (1990)
  • D. Bression et al.

    Endocrinology

    (1985)
  • R. Collu et al.

    Endocrinology

    (1988)
  • T. Di Paolo et al.

    Prog. Neuro-psycho-pharmacol. Biol. Psychiatry

    (1985)
  • S.V. Drouva et al.

    Endocrinology

    (1988)
  • Cited by (32)

    • Activation of D<inf>2</inf> dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs

      2013, Molecular and Cellular Endocrinology
      Citation Excerpt :

      Estrogen and dopamine antagonize each other to finely regulate lactotroph endocrine functions including the secretion (Lloyd et al., 1975; Raymond et al., 1978; West and Dannies, 1980) and synthesis of PRL (Maurer, 1982a), lactotroph proliferation (Elias and Weiner, 1987; Lloyd et al., 1975), and gene expression (Borgundvaag et al., 1992; Gómez and Balsa, 2004; Hyde et al., 1992). The antagonizing effect of estrogen on dopamine action is attributable to a decreased number of D2 receptors (Heiman and Ben-Jonathan, 1982; Kukstas et al., 1991; Pasqualini et al., 1986) or attenuated functional coupling of the D2 receptor with its downstream effectors (Gudelsky et al., 1981; Munemura et al., 1989) including guanine nucleotide regulatory proteins (Bouvier et al., 1991; Livingstone et al., 1998) and adenylate cyclase (Maus et al., 1989). Little is known, however, about the mechanism of the antagonizing effect of dopamine on estrogen action.

    View all citing articles on Scopus
    View full text